Prevenció de lesions en el futbol

Introducció: Les lesions més comuns en el futbol són les de turmell, genoll, pubàlgies i lesions musculars de tronc inferior. Actualment hi ha pocs estudis en quant a la seva prevenció i causa. Objectius: Conèixer les principals lesions degudes a la pràctica de futbol, la seva causa i incidència. Dissenyar mètodes de treball per a prevenir aquestes lesions, aplicar-los i si és possible validar els resultats obtinguts. Material i mètode: S’han aplicat i estudiat els mètodes de treballs dissenyats sobre un equip de futbol semi-professional de 19 jugadors de la Tercera Divisió Balear. Resultats: Amb el mètode aplicat s’ha reduït en un 45% la incidència de pubàlgies. Respecte a les altres lesions, no s’han observat millores. Conclusions: Els mètodes de prevenció de lesions són eficients per a prevenir lesions de pubis.Introduction: The most common injuries due to the football practice are ankle, knee, pubis and lower trunk muscle injuries. Currently there are not enough studies about its prevention and cause. Objectives: Recognize the main injuries due to the football practice, its cause and incidence. Design methods to prevent these injuries, apply them and if it’s possible validate the results. Material and methods: The methods designed have been implemented and studied on a semi-professional football team of Balearic Third Division, formed by 19 players. Results: The incidence of pubis injuries has been reduced around 45% of its incidence. About the other injuries there are not significant results. Conclusions: Injury prevention methods are effective to prevent pubis injuries

Endovascular treatment improves cognition after stroke. A secondary analysis of REVASCAT trial

Objective: To investigate the effect of endovascular treatment on cognitive function as a prespecified secondary analysis of the REVASCAT (Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours) trial. Methods: REVASCAT randomized 206 patients with anterior circulation proximal arterial occlusion stroke to Solitaire thrombectomy or best medical treatment alone. Patients with established dementia were excluded from enrollment. Cognitive function was assessed in person with Trail Making Test (TMT) Parts A and B at 3 months and 1 year after randomization by an investigator masked to treatment allocation. Test completion within 5 minutes, time of completion (seconds), and number of errors were recorded. Results: From November 2012 to December 2014, 206 patients were enrolled in REVASCAT. TMT was assessed in 82 of 84 patients undergoing thrombectomy and 86 of 87 control patients alive at 3 months and in 71 of 79 patients undergoing thrombectomy and 72 of 78 control patients alive at 1 year. Rates of timely TMT-A completion were similar in both treatment arms, although patients undergoing thrombectomy required less time for TMT-A completion and had higher rates of error-free TMT-A performance. Thrombectomy was also associated with a higher probability of timely TMT-B completion (adjusted odds ratio 3.17, 95% confidence interval 1.51-6.66 at 3 months; and adjusted ratio 3.66, 95% confidence interval 1.60-8.35 at 1 year) and shorter time for TMT-B completion. Differences in TMT completion times between treatment arms were significant in patients with good functional outcome but not in those who were functionally dependent (modified Rankin Scale score >2). Poorer cognitive outcomes were significantly associated with larger infarct volume, higher modified Rankin Scale scores, and worse quality of life. Conclusions: Thrombectomy improves TMT performance after stroke, especially among patients who reach good functional recovery. Classification of evidence: This study provides Class I evidence that for patients with stroke from acute anterior circulation proximal arterial occlusion, thrombectomy improves performance on the TMT at 3 months

Microchip multisensor de medida de flujo, temperatura y concentración de gases para el control de la combustión, procedimiento de fabricación y sus aplicaciones

Fecha de presentación internacional: 06.10.2004. - Titulares: Consejo Superior de Investigaciones Científicas (CSIC). - Copreci S. COOP. - Gas Natural SDA, S.A. - Universidad de Barcelona. - Fagor electrodomésticos S. COOP.[EN] The invention relates to the design and production of a microelectronic chip comprising an integrated assembly of gas flow and temperature sensors. The inventive microchip can be used to determine the concentrations of different gases in an environment, as well as the flow rates and temperatures thereof. The aforementioned measurements can be used to monitor combustion in a household furnace and to adjust the operation thereof in order to obtain safe, low-emission combustion.[ES] En la presente invención se reivindica el diseño y fabricación de un chip microelectrónico que integra un conjunto de sensores de gases, flujo y temperatura. Con este nuevo microchip es posible determinar las concentraciones de diversos gases en un ambiente, su caudal y temperatura. Dichas medidas permiten monitorizar la combustión en una caldera doméstica y actuar sobre su funcionamiento para conseguir una combustión baja en emisiones y segura.Peer reviewe

Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis.

BACKGROUND Whether pretreatment with intravenous thrombolysis prior to mechanical thrombectomy (IVT+MTE) adds additional benefit over direct mechanical thrombectomy (dMTE) in patients with large vessel occlusions (LVO) is a matter of debate. METHODS This study-level meta-analysis was presented in accord with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Pooled effect sizes were calculated using the inverse variance heterogeneity model and displayed as summary Odds Ratio (sOR) and corresponding 95% confidence interval (95% CI). Sensitivity analysis was performed by distinguishing between studies including dMTE patients eligible for IVT (IVT-E) or ineligible for IVT (IVT-IN). Primary outcome measures were functional independence (modified Rankin Scale≤2) and mortality at day 90, successful reperfusion, and symptomatic intracerebral hemorrhage. RESULTS Twenty studies, incorporating 5279 patients, were included. There was no evidence that rates of successful reperfusion differed in dMTE and IVT+MTE patients (sOR 0.93, 95% CI 0.68 to 1.28). In studies including IVT-IN dMTE patients, patients undergoing dMTE tended to have lower rates of functional independence and had higher odds for a fatal outcome as compared with IVT+MTE patients (sOR 0.78, 95% CI 0.61 to 1.01 and sOR 1.45, 95% CI 1.22 to 1.73). However, no such treatment group effect was found when analyses were confined to cohorts with a lower risk of selection bias (including IVT-E dMTE patients). CONCLUSION The quality of evidence regarding the relative merits of IVT+MTE versus dMTE is low. When considering studies with lower selection bias, the data suggest that dMTE may offer comparable safety and efficacy as compared with IVT+MTE. The conduct of randomized-controlled clinical trials seems justified

Endovascular treatment improves cognition after stroke. A secondary analysis of REVASCAT trial

Objective: To investigate the effect of endovascular treatment on cognitive function as a prespecified secondary analysis of the REVASCAT (Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours) trial. Methods: REVASCAT randomized 206 patients with anterior circulation proximal arterial occlusion stroke to Solitaire thrombectomy or best medical treatment alone. Patients with established dementia were excluded from enrollment. Cognitive function was assessed in person with Trail Making Test (TMT) Parts A and B at 3 months and 1 year after randomization by an investigator masked to treatment allocation. Test completion within 5 minutes, time of completion (seconds), and number of errors were recorded. Results: From November 2012 to December 2014, 206 patients were enrolled in REVASCAT. TMT was assessed in 82 of 84 patients undergoing thrombectomy and 86 of 87 control patients alive at 3 months and in 71 of 79 patients undergoing thrombectomy and 72 of 78 control patients alive at 1 year. Rates of timely TMT-A completion were similar in both treatment arms, although patients undergoing thrombectomy required less time for TMT-A completion and had higher rates of error-free TMT-A performance. Thrombectomy was also associated with a higher probability of timely TMT-B completion (adjusted odds ratio 3.17, 95% confidence interval 1.51-6.66 at 3 months; and adjusted ratio 3.66, 95% confidence interval 1.60-8.35 at 1 year) and shorter time for TMT-B completion. Differences in TMT completion times between treatment arms were significant in patients with good functional outcome but not in those who were functionally dependent (modified Rankin Scale score >2). Poorer cognitive outcomes were significantly associated with larger infarct volume, higher modified Rankin Scale scores, and worse quality of life. Conclusions: Thrombectomy improves TMT performance after stroke, especially among patients who reach good functional recovery. Classification of evidence: This study provides Class I evidence that for patients with stroke from acute anterior circulation proximal arterial occlusion, thrombectomy improves performance on the TMT at 3 months